Follow Us
A cure for type 1 diabetes
Read about the novel clinical study.
Diabetes researcher Denis Faustman, MD, PhD and colleagues at Massachusetts General Hospital (MGH) are using Mercodia´s C-Peptide kits in a novel type 1 diabetes clinical study.
The trial is testing whether using a generic drug to temporarily elevate tumor necrosis factor-alpha (TNF-a) levels in the body will reduce or eliminate autoimmune T cells in patients with established type 1 diabetes, an approach based on the Faustman lab’s previous success in reversing end-stage diabetes in mice. To learn more, please visit www.faustmanlab.org www.faustmanlab.org
Additional Links of Interest
Listen as Dr. Faustman describes her own research in "EFTR: Targeting Diabetes with an Old TB Vaccine"
03/04/13 Diabetic state can be efficiently reversed by insulin release from non-endocrine cells
03/03/13 Newsletter Issue 1, 2013
02/15/13 Zinc Transporter-8 does not have a substantial impact on mouse physiology
02/07/13 Words from our customer: Get accurate results, have more time for fun!
01/17/13 My life with type 1 diabetes
01/04/13 The effect of cocoa creams on cardiovascular disease